Lorena Raquel Lerner
Chief Science Officer, Keros Therapeutics, Inc.
Companies
- Keros Therapeutics, Inc.Chief Science Officer Aug 15, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Keros Therapeutics, Inc. KROS27,559 shares2$305.9K at $11.10Aug 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 18, 2026Sold 3,568 shares at $10.29 of Keros Therapeutics, Inc.2
- Feb 18, 2026Sold 3,873 shares at $16.35 of Keros Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 20, 2026